ArticleOncotarget2018

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.

Kazuyuki Numakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.